Iodipamide (free base)
featured

    WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 318062

CAS#: 606-17-7 (free base)

Description: Iodipamide (free base) is a molecule used as a contrast medium. When administered in vivo, iodipamide is removed from the liver and secreted into the biliary tract. Like other organic iodine compounds, this agent blocks x-rays and appears opaque on x-ray film; thereby it enhances the visibility of the bile ducts and gallbladder during cholangiography and cholecystography procedures.


Chemical Structure

img
Iodipamide (free base)
CAS# 606-17-7 (free base)

Theoretical Analysis

MedKoo Cat#: 318062
Name: Iodipamide (free base)
CAS#: 606-17-7 (free base)
Chemical Formula: C20H14I6N2O6
Exact Mass: 1,139.51
Molecular Weight: 1,139.762
Elemental Analysis: C, 21.08; H, 1.24; I, 66.81; N, 2.46; O, 8.42

Price and Availability

Size Price Availability Quantity
50mg USD 150 Ready to Ship
100mg USD 250 Ready to Ship
200mg USD 450 Ready to Ship
500mg USD 950 Ready to Ship
1g USD 1650 Ready to Ship
Bulk inquiry

Related CAS #: 606-17-7 (free base)   3521-84-4 (meglumine)   2618-26-0 (sodium)  

Synonym: Iodipamide, Adipiodone, Biligrafin, Iodipamic acid, Bilignost, Bilignostum

IUPAC/Chemical Name: 3-[[6-(3-carboxy-2,4,6-triiodoanilino)-6-oxohexanoyl]amino]-2,4,6-triiodobenzoic acid

InChi Key: FFINMCNLQNTKLU-UHFFFAOYSA-N

InChi Code: InChI=1S/C20H14I6N2O6/c21-7-5-9(23)17(15(25)13(7)19(31)32)27-11(29)3-1-2-4-12(30)28-18-10(24)6-8(22)14(16(18)26)20(33)34/h5-6H,1-4H2,(H,27,29)(H,28,30)(H,31,32)(H,33,34)

SMILES Code: O=C(O)C1=C(I)C=C(I)C(NC(CCCCC(NC2=C(I)C=C(I)C(C(O)=O)=C2I)=O)=O)=C1I

Appearance: Color: essentially colorless to light amber Form: Liquid

Purity: >98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: Soluble in DMSO, not in water

Shelf Life: >2 years if stored properly

Drug Formulation: This drug may be formulated in DMSO

Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code: 2934.99.9001

More Info:

Biological target:
In vitro activity:
In vivo activity:

Preparing Stock Solutions

The following data is based on the product molecular weight 1,139.76 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Formulation protocol:
In vitro protocol:
In vivo protocol:

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

1: Huang H, Zeng JP, Long Y. [Hyponatremia induced by iodipamide: three cases report]. Zhonghua Xin Xue Guan Bing Za Zhi. 2009 Jul;37(7):621. Chinese. PubMed PMID: 19961734.

2: Lee FT Jr, Sproat IA, Rappe AH, Violante MR, Bronson JP. Liver enhancement techniques in computed tomography. A comparison of intravenous bolus, computed tomographic portography, and iodipamide ethyl ester particle injections in a canine model. Invest Radiol. 1994 Jun;29 Suppl 2:S289-92. PubMed PMID: 7928259.

3: Yao SZ, Liu DZ, Nie LH. Potentiometric determination of iodipamide using an iodipamide ion-selective electrode. J Pharm Biomed Anal. 1990;8(4):373-7. PubMed PMID: 2100212.

4: Lauteala L, Kormano M, Violante MR. Accumulation and elimination of particulate iodipamide ethyl ester in the lungs and kidneys of the rat. A morphological study. APMIS. 1988 Jul;96(7):660-6. PubMed PMID: 3408591.

5: Sands MS, Violante MR, Gadeholt G. Computed tomographic enhancement of liver and spleen in the dog with iodipamide ethyl ester particulate suspensions. Invest Radiol. 1987 May;22(5):408-16. PubMed PMID: 3597009.

6: Lauteala L, Kormano M, Violante MR. Effect of intravenously administered iodipamide ethyl ester particles on rat liver morphology. Invest Radiol. 1984 Mar-Apr;19(2):133-41. PubMed PMID: 6533104.

7: Durda PJ, Pagano RJ, Bauman N, Brockman JA. Effects of iodipamide on human C3 and factor B in vitro. J Allergy Clin Immunol. 1982 Nov;70(5):353-60. PubMed PMID: 6922882.

8: Arndt RD, Joyce PW, Gray RK, Haveson SB, Bos CJ. Iodipamide-enhanced computed tomography of the pancreas. Radiology. 1981 May;139(2):491-3. PubMed PMID: 7220894.

9: Koenig H, Grimm I. [Animal experiment studies on the distribution of 125I-iodipamide-meglumine (adipiodon) in the rat]. Z Gesamte Hyg. 1981;27(6):435-7. German. PubMed PMID: 7269697.

10: Burgener FA, Fischer HW. The effect of bilirubin on biliary iodipamide excretion in the dog. Invest Radiol. 1980 Mar-Apr;15(2):162-7. PubMed PMID: 7372427.

11: Witcombe JB. Renal tubular sludging of meglumine iodipamide (Biligrafin). Br J Radiol. 1978 Aug;51(608):579-83. PubMed PMID: 678750.

12: Burgener FA, Fischer HW, Denyon TD. Biliary excretion of iodipamide and iodoxamate in normal and common bile duct-obstructed dogs. Invest Radiol. 1978 May-Jun;13(3):255-63. PubMed PMID: 581381.

13: Thompson WM, Jones RS, Lang JH, Amberg JR. Effect of iopanoate on the biliary and urinary excretion of iodipamide. Invest Radiol. 1978 Jan-Feb;13(1):79-84. PubMed PMID: 632052.

14: Lin SK, Moss AA, Riegelman S. Iodipamide kinetics: capacity-limited biliary excretion with simultaneous pseudo-first-order renal excretion. J Pharm Sci. 1977 Dec;66(12):1670-4. PubMed PMID: 925927.

15: Loeb PM, Barnhart JL, Berk RN. Iotroxamide--a new intravenous cholangiographic agent. Comparison with iodipamide and the effect of bile salts. Radiology. 1977 Nov;125(2):323-9. PubMed PMID: 578579.

16: Tanimura H, Takenaka M, Setoyama M, Kamata T. [Drip infusion cholecysto-cholangiography with iodoxamate (BC-17) (III). Especially, compared with iodipamide (author's transl)]. Nihon Geka Hokan. 1977 May 1;46(3):313-25. Japanese. PubMed PMID: 578092.

17: Sutherland LR, Edwards LA, Medline A, Wilkinson RW, Connon JJ. Meglumine iodipamide (Cholografin) hepatotoxicity. Ann Intern Med. 1977 Apr;86(4):437-9. PubMed PMID: 848806.

18: Meier F, Siegismund G, Götz J. [Protracted anaphylactic shock after methyl-glucamine iodipamide (author's transl)]. Med Klin. 1976 Nov 19;71(47):2077-9. German. PubMed PMID: 1004356.

19: Evill CA, Benness GT. Cholangiographic excretion studies: a comparison of iodipamide and iodoxamate in the dog. Invest Radiol. 1976 SEP-OCT;11(5):459-63. PubMed PMID: 989759.

20: Burgener FA, Fischer HW. The effect of sodium taurocholate on biliary iodipamide excretion in the dog. Gastroenterology. 1976 Sep;71(3):475-8. PubMed PMID: 950099.